EPISODE · Jun 23, 2026 · 2 MIN
Neurovalens CEO Outlines Noninvasive Neuromodulation Plans
from TheBrief.Health · host TheBrief.Health
Neurovalens’ Modius platform brings noninvasive neuromodulation into clinical practice, offering home-based FDA-authorized therapies for insomnia, anxiety, PTSD, and weight management, while facing evidence, reimbursement, and adoption challenges.
What this episode covers
Neurovalens’ Modius platform brings noninvasive neuromodulation into clinical practice, offering home-based FDA-authorized therapies for insomnia, anxiety, PTSD, and weight management, while facing evidence, reimbursement, and adoption challenges.
NOW PLAYING
Neurovalens CEO Outlines Noninvasive Neuromodulation Plans
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m